1Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report[J].JAMA, 2003,289 : 2560-2572.
2Elliott WJ, Black HR. Prehypertension[J]. Nat Clin Pract Cardiovasc Med,2007,4:538-548.
5Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker [J]. N Engl J Med, 2006,354 : 1685-1697.
6Skov K, Eiskjaer H, Hansen HE, et al. Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker[J].Hypertension, 2007,50 : 89-95.
7Luders S, Schrader J, Berger J, et al. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League[J]. J Hypertens, 2008,26 : 1487-1496.
8Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study[J]. JAMA, 2002,287 : 1003-1010.
9Israeli E, Korzets Z, Tekes-Manova D, et al. Blood-pressure categories in adolescence predict development of hypertension in accordance with the European guidelines[J].Am J Hypertens,2007, 20..705-709.
10Halperin RO, Gaziano JM, Sesso HD. Smoking and the risk of incident hypertension in middle-aged and older men[J]. Am J Hypertens,2008,21:148-152.
